Attached files
| file | filename |
|---|---|
| S-1 - S-1 - Tempest Therapeutics, Inc. | a13-9660_1s1.htm |
| EX-5.1 - EX-5.1 - Tempest Therapeutics, Inc. | a13-9660_1ex5d1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated February 25, 2013 in the Registration Statement on Form S-1 and related Prospectus of OvaScience, Inc. for the registration of 3,888,880 shares of its common stock.
/s/ Ernst & Young LLP
Boston, Massachusetts
April 12, 2013